13. Sleep Apnea: A Possible Complication of Cardiac Amyloidosis
Sleep apnea, a condition characterized by interrupted breathing during sleep, may be a complication of cardiac amyloidosis. The reduced heart function and fluid accumulation in the lungs can cause or exacerbate sleep apnea symptoms. Individuals with sleep apnea may experience loud snoring, gasping for air during sleep, and excessive daytime sleepiness.
Sleep apnea is a condition that is characterized by episodes of breathing cessation during sleep. It is a common disorder that affects millions of people worldwide. Sleep apnea can have serious consequences, including increased risk of cardiovascular disease, stroke, and cognitive impairment.
Recent studies have shown that sleep apnea is a possible complication of cardiac amyloidosis. The exact mechanism behind this association is not yet fully understood, but it is thought to be related to the accumulation of amyloid protein in the upper airway muscles, which can lead to narrowing of the airway and episodes of apnea during sleep.
The symptoms of sleep apnea can exacerbate the symptoms of cardiac amyloidosis, leading to increased fatigue, shortness of breath, and decreased exercise tolerance. In addition, sleep apnea can lead to a further increase in the risk of cardiovascular disease, which is already elevated in patients with cardiac amyloidosis.
Sleep apnea is a possible complication of cardiac amyloidosis, and it can have a significant impact on the quality of life and health outcomes of affected individuals. It is important for healthcare providers to be aware of this association and to consider screening for sleep apnea in patients with cardiac amyloidosis. If you suspect you have sleep apnea, consult a healthcare professional for evaluation and potential treatment options. (13)
